Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
- 28 April 1999
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 38 (6) , 735-767
- https://doi.org/10.1016/s0028-3908(99)00019-2
Abstract
No abstract availableKeywords
This publication has 251 references indexed in Scilit:
- Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in ratsHepatology, 1997
- Selective Loss of Binding Sites for the Glutamate Receptor Ligands [3H]Kainate and (S)–[3H]5–Fluorowillardiine in the Brains of Rats With Acute Liver FailureHepatology, 1997
- Transient expression of NMDA receptors during rearrangement of AMPA-receptor-expressing fibers in the developing inner earCell and tissue research, 1996
- Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: Eliprodil, ifenprodil and other native NMDA receptor subtype selective compoundsNeurochemistry International, 1996
- Interactions of excitatory amino acid antagonists with conventional antiepileptic drugsMetabolic Brain Disease, 1996
- Neuroactive amino acids in hepatic encephalopathyMetabolic Brain Disease, 1996
- Antagonists of the NMDA receptor-channel complex and motor coordinationLife Sciences, 1995
- Excitatory amino acids: Implications for psychiatric disorders researchLife Sciences, 1994
- Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992